| Home Market Dynamics Sector Analysis Company Insights AI Investing Strategies Contact Us Login |
| Eli Lilly is focusing on significant advancements in drug manufacturing and innovative treatment development, with key efforts in building new facilities to boost production capacity for its obesity drug. The company’s ongoing research in incretin therapies presents a promising outlook for market expansion. However, challenges remain due to recent setbacks in clinical trials, which may hinder the progress of new therapeutic options. Balancing these positive developments with the risks from halted trials will be crucial for future growth. |
| The price action of Eli Lilly (LLY) is impacted by broad market risk appetite, sector price trend, company-specific performance and market structure. The market sentiment at -0.1 is modestly bearish. Trend sentiment measures the current trend of the stock price, and market sentiment reflects what market participants collectively think where the price will move next.There is no clear direction for LLY since trend sentiment and market sentiment are at the opposite directions. The positive sentiment force for sector is at 0.1, and the negative at -0.2 on 2025-09-29. The forces of and Valuation Sentiment (-1) will drive down the price. The forces of Stock Price Trend (0), Sector Price Trend (0), Price Level Sentiment (0), Option Sentiment (0), Market Risk Appetite (0), and Sentiment towards Fundamentals (0.7) will drive up the price. The sentiment for Sector Price Trend is calculated based on the price trend of related sector ETF. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Appetite is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. The price level reaches 100 at Bollinger upper band, and zero at lower band. |
| LLY | |||||||||||||
| Date | Attention | Price | Price Level | Change | SMA10 Trend | Trend Sentiment | Hourly Trend | Hourly StdDev | Market Sentiment | Action | P | Fund. | News Sentiment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-09-29 | 0%(0%) | 0 | 0% | -0.1 | 0.7 | -1 | |||||||
| 2025-09-28 | 0%(0%) | 0 | 0% | -0.1 | 0.4 | -1 | |||||||
| 2025-09-27 | 0%(0%) | 0 | 0% | -0.1 | 0.4 | -1 | |||||||
| 2025-09-26 | 0%(0%) | 0 | 0% | 0.1 | 1.4 | 6 | |||||||
| 2025-09-25 | 0%(0%) | 0 | 0% | -0.1 | 0.5 | -6 | |||||||
| 2025-09-24 | 0%(0%) | 0 | 0% | 0.1 | 1.6 | -1 | |||||||
| 2025-09-23 | 0%(0%) | 0 | 0% | 0.1 | 1.8 | 5.5 | |||||||
| 2025-09-22 | 0%(0%) | 0 | 0% | 0 | 1.1 | -1 | |||||||
| 2025-09-21 | 0%(0%) | 0 | 0% | -0.1 | 0.6 | -1 | |||||||
| 2025-09-20 | 0%(0%) | 0 | 0% | -0.1 | 0.6 | -1 | |||||||
| Wait action is recommended in three scenarios with either high uncertainty or high risk: 1. The trend sentiment and market sentiment are at the opposite directions. 2. Both trend sentiment and market sentiment are positive, but the price level is elevated. 3. Both trend sentiment and market sentiment are negative, but the price level is depressed. In an uptrend, as an investor, you may want to wait for the pullback to open long position. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position. | |||||||||||||
| Market sentiment will accelerate the current trend when both trend sentiment and market sentiment are at the same direction. Market sentiment will generate volatility when it's at the opposite direction of the trend sentiment. News sentiment measures the daily emotion of the market. News sentiment may impact the daily price change while market sentiment is a more stable and consistent moving force. | |||||||||||||
| 2025-09-29 17:02:36 Trends suggest a shift towards medication that could address multiple conditions, including weight loss and Alzheimer's, impacting the pharmaceutical industry. |
| 2025-09-29 17:02:36 The earnings potential for Eli Lilly is good due to growing revenues and robust pipeline developments. |
| 2025-09-29 17:02:36 The competitive landscape with Novo Nordisk emphasizes the importance of Eli Lilly's product offerings and market strategies. |
| 2025-09-29 17:02:36 Eli Lilly's advancements in innovative treatments, such as incretin therapies, show promise for growth and market expansion. |
| 2025-09-29 17:02:36 The articles highlight Eli Lilly's stock performance, noting recent gains and potential for future growth. |